Vivos Therapeutics, Inc.
VVOS
$0.80
$0.022.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -67.59% | -51.09% | -36.23% | -10.30% | 281.01% |
| Total Receivables | 267.67% | 370.04% | 313.42% | 36.76% | 112.87% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -1.15% | -10.88% | 25.45% | 15.16% | 27.11% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -41.34% | -21.80% | -14.29% | -0.11% | 203.66% |
|
|
|||||
| Total Current Assets | -41.34% | -21.80% | -14.29% | -0.11% | 203.66% |
| Net Property, Plant & Equipment | 82.43% | 102.99% | 87.06% | -8.09% | -7.58% |
| Long-term Investments | 201.51% | 197.22% | 197.22% | 0.00% | 0.00% |
| Goodwill | 201.51% | 197.22% | 197.22% | 0.00% | 0.00% |
| Total Other Intangibles | 889.00% | 467.10% | 463.29% | -12.25% | -2.62% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.56% | -23.55% | -7.61% | -30.19% | -29.64% |
| Total Assets | 64.56% | 67.09% | 64.33% | -4.42% | 42.44% |
|
|
|||||
| Total Accounts Payable | 52.91% | 95.63% | -13.07% | -51.74% | -48.81% |
| Total Accrued Expenses | 168.04% | 30.57% | 5.35% | -27.66% | -4.28% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,803.56% | 132.58% | 78.93% | -3.31% | 0.63% |
| Total Finance Division Other Current Liabilities | 13.69% | 0.79% | -23.18% | -52.56% | -49.96% |
| Total Other Current Liabilities | 13.69% | 0.79% | -23.18% | -52.56% | -49.96% |
| Total Current Liabilities | 263.12% | 45.08% | -3.27% | -41.75% | -31.71% |
|
|
|||||
| Total Current Liabilities | 263.12% | 45.08% | -3.27% | -41.75% | -31.71% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 281.93% | 158.29% | 130.86% | -33.38% | -31.95% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 219.21% | 207.94% | 174.11% | -29.15% | -12.72% |
| Total Liabilities | 264.28% | 200.86% | 125.91% | -38.74% | -28.97% |
|
|
|||||
| Common Stock & APIC | 10.46% | 10.98% | 11.95% | 15.46% | 19.99% |
| Retained Earnings | -20.32% | -16.87% | -14.50% | -11.61% | -11.97% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -118.73% | -66.97% | -27.79% | 657.22% | 1,835.28% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -118.73% | -66.97% | -27.79% | 657.22% | 1,835.28% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -119.49% | -66.97% | -27.79% | 657.22% | 1,835.28% |
|
|
|||||